Assyro AI

Orange Book product · Generic (ANDA)

LANTHANUM CARBONATE

LANTHANUM CARBONATE

Generic (ANDA)ANDA 202329TE ABRX ALKEM LABS LTD

At a glance

Mar 13, 2025

Approved

Generic (ANDA)

Application

AB

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Mar 13, 2025

    1 yr 3 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

LANTHANUM CARBONATE

Strength

EQ 1GM BASE

Dosage form

TABLET, CHEWABLE

Route

ORAL

TE code

AB

Application

ANDA 202329

Product number

003

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of LANTHANUM CARBONATE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.